Considering the fact that U. S. Open is a dream of every golfer, Bernd Wiesberger was found saying that he has been targeting the competition. He wishes to be the first Austrian to achieve the feat.
Presently, he stands at number 61. In order to find a place for next week's major in Ardmore, Pa, he has to be in top-10. In recent Nordea Masters in Sweden, Wiesberger has touched third position.
He said, "I've played a couple of events in the United States before so it's not really like being in uncharted waters. Still, it would be a huge honor being the first Austrian to play at the U. S. Open. But I am not calculating and will just try to play well here”.
His statistics say that he has had a great record in Atzenbrugg. In 2011, he finished at fifth position. He has been positioned on this number due to his recent achievements. He has won Indonesian Masters recently. This was third win for him. Before this, there has been Ballantine's Championship in South Korea and Lyoness Open in 2012.
Bernd Wiesberger is working hard to play perfect golf. He believes there is always a place for improvement and he will work on his weaknesses.
According to a post published to Microsoft’s official blog on Wednesday, the number of devices running the company’s latest Windows version -- the Windows 10 operating system -- has touched 350 million.
The new milestone in the Windows 10...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
The Verge has revealed in a Wednesday report, citing a statement released by Lexus, that the working of the head units of a number of vehicles has been affected because of an over-the-air (OTA) update recently rolled out by the company.
...
The drought conditions in California is widening economic split in California. The prospect of...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
A panel of US medical experts said that there is no...
At the GSMA Mobile World Congress in Shanghai, HTV Vive...
According to a post published to Microsoft’s official...
No matter how dangerous a task it seems to look within a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).